UCHL1 and Parkinson disease: The protective mechanism of 6RK73 against PD, attributed to its ability to address reduced UCHL1 activity linked to neurodegenerative diseases, presents a novel approach to modulating post-translational modifications (PTMs) (Kooij et al. 2020).